The global artificial intelligence in epidemiology market size was evaluated at USD 548.99 million by 2023 and is projected to gain around USD 6,025.53 million by 2033 with a CAGR of 27.07% between 2024 and 2033.
Key Points
- North America dominated the artificial intelligence in epidemiology market in 2023.
- Europe is expected to grow at a notable rate in the market during the forecast period.
- By deployment, the cloud-based segment will dominate the market in 2023.
- By deployment, the web-based segment is expected to grow at the highest CAGR in the market during the forecast period.
- By application, the prediction & forecasting segment dominated the market in 2023.
- By application, the disease & syndromic surveillance segment is expected to grow at the highest CAGR in the market during the forecast period.
- By end-use, the pharmaceuticals and biotechnology companies segment dominated the market in 2023.
- By end-use, the research labs segment is expected to grow at a significant CAGR in the market during the forecast period.
Market Overview
The Artificial Intelligence in Epidemiology Market has been witnessing substantial growth in recent years, driven by the increasing integration of advanced AI technologies in the field of public health. AI in epidemiology leverages machine learning, data analytics, and predictive modeling to improve disease surveillance, outbreak prediction, and health outcome monitoring. These technologies enable faster and more accurate data analysis, aiding health professionals in making informed decisions to control and prevent disease spread. The market encompasses a variety of AI applications, including natural language processing, image recognition, and bioinformatics, which are utilized in epidemiological research and public health initiatives.
Get the Sample Copy of This Report@ https://www.precedenceresearch.com/sample/4458
Growth Factors
Several key factors contribute to the growth of the AI in Epidemiology Market. First, the rising incidence of infectious diseases and the need for rapid response and management have accelerated the adoption of AI solutions. Second, advancements in AI algorithms and the increasing availability of big data in healthcare have enhanced the accuracy and efficiency of epidemiological models. Third, growing investments from governments and private organizations in AI and healthcare infrastructure are bolstering market expansion. Additionally, the COVID-19 pandemic has underscored the critical role of AI in managing public health crises, further propelling market growth.
Artificial Intelligence in Epidemiology Market Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 548.99 Million |
| Market Size in 2024 | USD 697.60 Million |
| Market Size by 2033 | USD 6,025.53 Million |
| Market Growth Rate | CAGR of 8.92% from 2024 to 2033 |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Deployment, Application Infection, End-use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Dynamics
Drivers
The primary drivers of the AI in Epidemiology Market include the increasing demand for precision medicine and personalized healthcare, which require advanced data analytics capabilities. The ability of AI to process large volumes of complex health data quickly and accurately is a significant driver. Moreover, the integration of AI in digital health platforms and wearable devices facilitates real-time monitoring and early detection of disease outbreaks. The rising focus on preventive healthcare and the need to reduce healthcare costs through efficient disease management also drive market growth. Furthermore, partnerships between technology firms and healthcare providers are accelerating the development and deployment of AI solutions in epidemiology.
Opportunities
The AI in Epidemiology Market presents numerous opportunities for growth and innovation. One major opportunity lies in the development of AI-driven predictive models for emerging infectious diseases, which can enhance preparedness and response strategies. Additionally, the integration of AI with Internet of Things (IoT) devices and mobile health applications can improve disease tracking and health monitoring in real-time. There is also significant potential in leveraging AI for genomic studies and bioinformatics to understand disease patterns and genetic predispositions. Expanding AI applications in telemedicine and remote health monitoring offers further opportunities for improving public health outcomes, particularly in underserved regions.
Challenges
Despite its potential, the AI in Epidemiology Market faces several challenges. One of the primary challenges is data privacy and security concerns, as the handling of sensitive health information requires stringent safeguards to protect patient confidentiality. Another challenge is the need for high-quality, standardized data to train AI models effectively. The lack of interoperability among various health information systems can hinder seamless data integration and analysis. Additionally, there is a shortage of skilled professionals with expertise in both AI and epidemiology, which can limit the effective implementation of AI solutions. Regulatory and ethical considerations also pose challenges, as the use of AI in healthcare must comply with legal frameworks and ethical standards.
Region Insights
Regionally, the AI in Epidemiology Market shows varying degrees of adoption and growth. North America, particularly the United States, leads the market due to its advanced healthcare infrastructure, significant investments in AI research, and strong presence of key technology players. Europe follows, with countries like the UK, Germany, and France investing heavily in digital health initiatives and AI technologies. The Asia-Pacific region is experiencing rapid growth, driven by increasing healthcare expenditures, government initiatives, and the rising prevalence of infectious diseases. Countries like China, India, and Japan are at the forefront of AI adoption in epidemiology. Meanwhile, Latin America and the Middle East & Africa are gradually embracing AI solutions, with growing awareness and investments in healthcare technologies.
Read Also: https://www.businesswebwire.com/microneedling-market/
Artificial Intelligence (AI) in Epidemiology Market Companies
- Cerner Corporation
- Cognizant
- eClinical Works Inc
- Alphabet Inc
- Intel Corporation
- Epic Systems Corporation
- Microsoft Corporation
- Meditech
- Komodo Health
- Siemens Healthineers
- Bayer Healthcare
- SAS Institute
- Cardiolyse
- Predixion Healthcare (Jvion LLC)
Recent Developments
- In September 2023, The Department of Biomedical Informatics (DBMI) at Harvard Medical School is creating an AI in Medicine Ph.D. track to prepare the next generation of leaders at the intersection of artificial intelligence and medicine. Applications were opened in September 2023 for a program started in the fall of 2024.
- In August 2023, Clarivate Plc, a global leader in connecting people and organizations to intelligence they can trust to transform their world, launched its new enhanced search platform leveraging generative artificial intelligence (GenAI). GenAI has the potential to yield efficiencies across the entire Life Sciences & Healthcare value chain.
- In June 2023, Dartmouth launched its Center for Precision Health and Artificial Intelligence (CPHAI), which is set to advance interdisciplinary research into how artificial intelligence (AI) and biomedical data can be used to improve precision medicine and health outcomes. CPHAI’s launch is supported by $2 million in initial funding from Dartmouth’s Geisel School of Medicine and the Dartmouth Cancer Center.
Segment Covered in the Report
By Deployment
- Web-based
- Cloud-based
By Application Infection
- Prediction and forecasting
- Disease and syndromic surveillance
By End-use
- Government and state Agencies
- Research labs
- Pharmaceutical and Biotechnology Companies
- Healthcare Providers
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.dailystatsnews.com/